• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Naphthyridines

Recent Advances in the Study of 8-Bromo-1,6-naphthyridine (CAS: 17965-74-1) in Chemical Biology and Pharmaceutical Research

8-Bromo-1,6-naphthyridine (CAS: 17965-74-1) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its brominated naphthyridine core, serves as a key intermediate in the synthesis of various bioactive molecules and has shown promise in drug discovery efforts. Recent studies have explored its potential as a building block for novel therapeutic agents, particularly in the fields of oncology and infectious diseases.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 8-Bromo-1,6-naphthyridine as a precursor for the development of kinase inhibitors. Researchers successfully incorporated this scaffold into compounds targeting specific tyrosine kinases implicated in cancer progression. The bromine atom at the 8-position was found to be crucial for molecular interactions within the ATP-binding pocket of these kinases, as revealed by X-ray crystallography studies.

In antimicrobial research, 8-Bromo-1,6-naphthyridine derivatives have shown remarkable activity against drug-resistant bacterial strains. A recent publication in Bioorganic & Medicinal Chemistry Letters (2024) reported the synthesis of a series of 1,6-naphthyridine analogs bearing various substitutions at the 8-position. Among these, the bromo-substituted derivative exhibited superior potency against methicillin-resistant Staphylococcus aureus (MRSA), with minimum inhibitory concentrations (MICs) in the low micromolar range.

The compound's photophysical properties have also been investigated for potential applications in bioimaging. A 2024 study in Chemical Communications described the development of fluorescent probes based on 8-Bromo-1,6-naphthyridine scaffolds. These probes demonstrated excellent cell permeability and selective staining of cellular organelles, making them valuable tools for live-cell imaging studies.

From a synthetic chemistry perspective, recent advances have focused on developing more efficient routes to 8-Bromo-1,6-naphthyridine and its derivatives. A novel one-pot synthesis method published in Organic Letters (2023) significantly improved the yield and purity of the compound while reducing the number of synthetic steps. This methodological advancement is expected to facilitate broader exploration of its pharmaceutical applications.

In drug metabolism studies, researchers have investigated the pharmacokinetic properties of 8-Bromo-1,6-naphthyridine-containing compounds. A 2024 paper in Drug Metabolism and Disposition reported favorable metabolic stability and oral bioavailability for several lead compounds incorporating this scaffold, suggesting its potential for further development as drug candidates.

Looking forward, the unique structural features of 8-Bromo-1,6-naphthyridine continue to inspire innovative research across multiple disciplines. Its combination of synthetic accessibility, structural diversity, and biological activity makes it a valuable tool for medicinal chemists. Future research directions may include exploration of its applications in targeted protein degradation, covalent inhibitor design, and as a component of supramolecular drug delivery systems.

• 51417-51-7(7-Bromo-1H-indole)
• 5332-24-1(3-Bromoquinoline)
• 16567-18-3(8-Bromoquinoline)
• 23612-36-4(3-Bromo-1H-pyrrolo[3,2-c]pyridine)
• 1070879-31-0(4,8-Dibromoquinoline)
• 902837-42-7(7-Bromo-1H-pyrrolo[3,2-c]pyridine)
• 69268-39-9(3,6-Dibromoquinoline)
• 90224-68-3(Quinoline, 3-bromo-, hydrochloride)
• 81278-86-6(5,8-Dibromoquinoline)
• 1081803-09-9(8-Bromoquinoline hydrochloride)